bosentan anhydrous has been researched along with Wounds and Injuries in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guc, MO; Iskit, AB; Senel, I; Sokmensuer, C | 1 |
1 other study(ies) available for bosentan anhydrous and Wounds and Injuries
Article | Year |
---|---|
Endothelin receptor antagonist bosentan improves survival in a murine caecal ligation and puncture model of septic shock.
Topics: Animals; Antihypertensive Agents; Bosentan; Cecum; Disease Models, Animal; Endothelin Receptor Antagonists; Kidney; Ligation; Liver; Mice; Shock, Septic; Sodium Chloride; Spleen; Sulfonamides; Survival Rate; Time Factors; Wounds and Injuries | 2004 |